A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease

Abstract

In this short-term study in patients with Alzheimer's disease who were selected for apparent responsiveness to tacrine, treatment with tacrine resulted in a statistically significant reduction in the decline of cognitive function, although this reduction was not large enough to be detected by the study physicians' global assessments of the patients.